biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Tiger86on May 02, 2019 3:49pm

92 Views

Post# 29702778

RE:JD stock or should I say JD Trump?

Wow trussel09 - you sure did bring a lot of value to the board with that post !! What else are you going to blame JD for?

Be thankful that RVX has been increasing in share price and hope that the trial results are favourable rather than complaining about JD and the BTI share price. I'm sure there are a lot of BTI shareholders who are not happy with the price but we don't blame JD for it. He didn't force anyone to buy the stock.

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale